Natixis Investment Managers International’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-9,449
Closed -$493K 272
2022
Q2
$493K Sell
9,449
-3,320
-26% -$189K 0.01% 295
2022
Q1
$724K Buy
+12,769
New +$684K 0.01% 252
2018
Q4
Sell
-10,146
Closed -$548K 108
2018
Q3
$548K Sell
10,146
-2,226
-18% -$114K 0.03% 454
2018
Q2
$604K Buy
12,372
+8,986
+265% +$510K 0.03% 382
2018
Q1
$212K Buy
+3,386
New +$232K 0.02% 350
2016
Q3
Sell
-2,721
Closed -$212K 372
2016
Q2
$212K Buy
+2,721
New +$217K 0.02% 342
2015
Q4
Sell
-1,942
Closed -$149K 410
2015
Q3
$149K Buy
+1,942
New +$162K 0.02% 341

Other funds holding CAH

Natixis Investment Managers International's CAH Position: Q3 2022 in Review

Natixis Investment Managers International sold out of Cardinal Health (CAH) in Q3 2022, closing a stake of 9,449 shares — an estimated $493K sold.

Natixis Investment Managers International first reported a position in CAH in Q3 2015 and held it in 7 quarters. The position peaked at $724K in Q1 2022. 850 funds tracked by Wall St. Rank hold CAH as of Q3 2022.

  • Natixis Investment Managers International reported no remaining Cardinal Health position as of Q3 2022 after selling out during the quarter.
  • Natixis Investment Managers International sold 9,449 Cardinal Health shares in Q3 2022, an estimated $493K.
  • Natixis Investment Managers International first reported a position in Cardinal Health in Q3 2015 and held it in 7 quarters.
  • Natixis Investment Managers International's Cardinal Health position peaked at $724K in Q1 2022.
  • 850 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2022.

Based on Natixis Investment Managers International's 13F filing for Q3 2022, filed 14 Nov 2022.